1,433
Views
10
CrossRef citations to date
0
Altmetric
Coronaviruses

Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally infected, captive white-tailed deer (Odocoileus virginianus), Texas

ORCID Icon, , , , , , , , , , ORCID Icon & ORCID Icon show all
Pages 2112-2115 | Received 27 Jun 2022, Accepted 09 Aug 2022, Published online: 31 Aug 2022

References

  • Palermo PM, Orbegozo J, Watts DM, et al. SARS-CoV-2 neutralizing antibodies in white-tailed deer from Texas. Vector Borne Zoonotic Dis. 2022 Jan;22(1):62–64.
  • Chandler JC, Bevins SN, Ellis JW, et al. SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus). Proc Natl Acad Sci U S A. 2021 Nov 23;118(47):e2114828118.
  • Cool K, Gaudreault NN, Morozov I, et al. Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer. Emerg Microbes & Infect. 2022;11(1):95–112.
  • Palmer MV, Martins M, Falkenberg S, et al. Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2. J Virol. 2021 Jun;95(11):e00083-21.
  • Kuchipudi SV, Surendran-Nair M, Ruden RM, et al. Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer. Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):e2121644119.
  • Hale VL, Dennis PM, McBride DS, et al. SARS-CoV-2 infection in free-ranging white-tailed deer. Nature. 2022 Feb;602(7897):481–486.
  • Pickering B, Lung O, Maguire F, et al. Highly divergent white-tailed deer SARS-CoV-2 with potential deer-to-human transmission. BioRXIV. 2022. doi:10.1101/2022.02.22.481551
  • Roundy CM, Nunez CM, Thomas LF, et al. High seroprevalence of SARS-CoV-2 in white-tailed deer (Odocoileus virginianus) at one of three captive cervid facilities in Texas. Microbiol Spectr. 2022 Apr 27;10(2):e0057622.
  • Beaty BC, Calisher CH, Shope RE. Arboviruses. In: Lennette EH, Schmidt NJ, editor. Viral, Rickettsial, and Chlamydial infections. Washington, DC: American Public Health Association; 1995. p. 189–212.
  • Pauvolid-Corrêa A, Caetano BC, Machado AB, et al. Humoral immune response of patients infected by earlier lineages of SARS-CoV-2 neutralizes wild types of the most prevalent variants in Brazil. medRxiv. 2022. doi:10.1101/2022.01.24.22269379.
  • WHO. Coronavirus (COVID-19) 2022 [cited 2022 Mar 17]. Available from: https://covid19.who.int.
  • Haveri A, Ekström N, Solastie A, et al. Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans. Eur J Immunol. 2021;51(12):3202–3213.
  • Martins M, Boggiatto PM, Buckley A, et al. From deer-to-deer: SARS-CoV-2 is efficiently transmitted and presents broad tissue tropism and replication sites in white-tailed deer. Plos Pathog. 2022 Mar;18(3):e1010197.
  • Bosco-Lauth AM, Hartwig AE, Porter SM, et al. Experimental infection of domestic dogs and cats with SARS-CoV-2: pathogenesis, transmission, and response to reexposure in cats. Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382–26388.
  • Naveca FG, Nascimento VA, Nascimento F, et al. A case series of SARS-CoV-2 reinfections caused by the variant of concern gamma in Brazil. medRxiv. 2021. doi:10.1101/2021.11.29.21266109.
  • Purushotham JN, Van Doremalen N, Munster VJ. SARS-CoV-2 vaccines: anamnestic response in previously infected recipients. Cell Res. 2021;31(8):827–828.
  • Muruato AE, Fontes-Garfias CR, Ren P, et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2021 Jun 22;12(1):4000.